About this event
For the past 20 years there has been an extraordinary opioid overdose epidemic in the United States. The epidemic began with the misuse and misunderstanding of prescription opioid analgesics for the treatment of chronic non-cancer pain. The epidemic then shifted to heroin and is now primarily driven by fentanyl and its analogues. Dr. Salsitz will review the evolution of this epidemic and the measures taken to stem the tide of opioid misuse, the CDC guidelines and misconceptions about the guidelines, as well as the current standard of treatment for opioid use disorder.
Who can attend
Registration is limited to ISMIE and SEMPIC policyholders and their employed staff.
Learning objectives
At the conclusion of this learning activity, participants will be able to:
- Describe the “perfect storm” leading to the prescription opioid epidemic
- Summarize the CDC guidelines for the treatment of chronic pain and its misinterpretation by clinicians
- Discuss the safe disposal of opioid medication
- Describe the treatment of opioid use disorder
About the presenter
Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel, Division of Addiction Medicine, New York City, since 1983, and is an Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified in Addiction Medicine by the American Board of Preventive Medicine, as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.
Dr. Salsitz is a course director for ASAM sponsored Buprenorphine and REMS safe opioid prescribing trainings, and is a lead mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee.
Dr Salsitz teaches addiction medicine at the Icahn School of Medicine at Mount Sinai, to third year medical students, masters of science students, neuroscience PH.D candidates, and psychiatry residents. He is a frequent contributor and presenter at the Addiction Club, lead by Dr. Hurd.
Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.
Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Illinois State Medical Society and ISMIE Mutual Insurance Company. The Illinois State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Illinois State Medical Society designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.
ISMIE Risk Management
Our Passion Protects YoursISMIE Mutual provides superior insurance services to medical practices and providers, delivering quality, value and protection to policyholders everywhere.
